183 related articles for article (PubMed ID: 32326813)
1. "I'm doing this test so I can benefit from PrEP": exploring HIV testing barriers/facilitators and implementation of pre-exposure prophylaxis among South African adolescents.
Yoshioka E; Giovenco D; Kuo C; Underhill K; Hoare J; Operario D
Afr J AIDS Res; 2020 Jul; 19(2):101-108. PubMed ID: 32326813
[TBL] [Abstract][Full Text] [Related]
2. Adolescent-Centered HIV Prevention: Perspectives on Acceptability of Oral Antiretroviral Pre-exposure Prophylaxis for Adolescents in a Global Priority Setting.
Giovenco D; Kuo C; Underhill K; Hoare J; Operario D
Arch Sex Behav; 2021 Oct; 50(7):2921-2931. PubMed ID: 34561792
[TBL] [Abstract][Full Text] [Related]
3. "The Time Has Arrived": Perceptions of Behavioral Adjustments in the Context of Pre-Exposure Prophylaxis Availability Among Adolescents in South Africa.
Giovenco D; Kuo C; Underhill K; Hoare J; Operario D
AIDS Educ Prev; 2018 Dec; 30(6):463-473. PubMed ID: 30966763
[TBL] [Abstract][Full Text] [Related]
4. Exploring Perceived Barriers and Facilitators of PrEP Uptake among Young People in Uganda, Zimbabwe, and South Africa.
Muhumuza R; Ssemata AS; Kakande A; Ahmed N; Atujuna M; Nomvuyo M; Bekker LG; Dietrich JJ; Tshabalala G; Hornschuh S; Maluadzi M; Chibanda-Stranix L; Nematadzira T; Weiss HA; Nash S; Fox J; Seeley J
Arch Sex Behav; 2021 May; 50(4):1729-1742. PubMed ID: 33954824
[TBL] [Abstract][Full Text] [Related]
5. The influence of HIV-related stigma on PrEP disclosure and adherence among adolescent girls and young women in HPTN 082: a qualitative study.
Velloza J; Khoza N; Scorgie F; Chitukuta M; Mutero P; Mutiti K; Mangxilana N; Nobula L; Bulterys MA; Atujuna M; Hosek S; Heffron R; Bekker LG; Mgodi N; Chirenje M; Celum C; Delany-Moretlwe S;
J Int AIDS Soc; 2020 Mar; 23(3):e25463. PubMed ID: 32144874
[TBL] [Abstract][Full Text] [Related]
6. Stigma in the health clinic and implications for PrEP access and use by adolescent girls and young women: conflicting perspectives in South Africa.
Nyblade L; Ndirangu JW; Speizer IS; Browne FA; Bonner CP; Minnis A; Kline TL; Ahmed K; Howard BN; Cox EN; Rinderle A; Wechsberg WM
BMC Public Health; 2022 Oct; 22(1):1916. PubMed ID: 36242000
[TBL] [Abstract][Full Text] [Related]
7. Pre-exposure prophylaxis as an opportunity for engagement in HIV prevention among South African adolescents.
LoVette A; Kuo C; Giovenco D; Hoare J; Underhill K; Operario D
SAHARA J; 2022 Dec; 19(1):1-7. PubMed ID: 35135437
[TBL] [Abstract][Full Text] [Related]
8. Strengthening health system's capacity for pre-exposure prophylaxis for adolescent girls and young women and adolescent boys and young men in South Africa (SHeS'Cap-PrEP): Protocol for a mixed methods study in KwaZulu-Natal, South Africa.
Nicol E; Ramraj T; Hlongwa M; Basera W; Jama N; Lombard C; McClinton-Appollis T; Govindasamy D; Pass D; Funani N; Aheron S; Paredes-Vincent A; Drummond J; Cheyip M; Dladla S; Bedford J; Mathews C
PLoS One; 2022; 17(3):e0264808. PubMed ID: 35298487
[TBL] [Abstract][Full Text] [Related]
9. A qualitative study to explore daily versus on-demand oral pre-exposure prophylaxis (PrEP) in young people from South Africa, Uganda and Zimbabwe.
Dietrich JJ; Ahmed N; Tshabalala G; Wu M; Mulaudzi M; Hornschuh S; Atujuna M; Muhumuza R; Ssemata AS; Stranix-Chibanda L; Nematadzira T; Bekker LG; Martinson N; Seeley J; Fox J
PLoS One; 2023; 18(6):e0287627. PubMed ID: 37384792
[TBL] [Abstract][Full Text] [Related]
10. Acceptability, safety, and patterns of use of oral tenofovir disoproxil fumarate and emtricitabine for HIV pre-exposure prophylaxis in South African adolescents: an open-label single-arm phase 2 trial.
Gill K; Johnson L; Dietrich J; Myer L; Marcus R; Wallace M; Pidwell T; Mendel E; Fynn L; Jones K; Wiesner L; Slack C; Strode A; Spiegel H; Hosek S; Rooney J; Gray G; Bekker LG
Lancet Child Adolesc Health; 2020 Dec; 4(12):875-883. PubMed ID: 33222803
[TBL] [Abstract][Full Text] [Related]
11. PrEP awareness and engagement among transgender women in South Africa: a cross-sectional, mixed methods study.
Poteat T; Malik M; van der Merwe LLA; Cloete A; Adams D; Nonyane BAS; Wirtz AL
Lancet HIV; 2020 Dec; 7(12):e825-e834. PubMed ID: 32622370
[TBL] [Abstract][Full Text] [Related]
12. Preventing HIV among adolescents with oral PrEP: observations and challenges in the United States and South Africa.
Hosek S; Celum C; Wilson CM; Kapogiannis B; Delany-Moretlwe S; Bekker LG
J Int AIDS Soc; 2016; 19(7(Suppl 6)):21107. PubMed ID: 27760684
[TBL] [Abstract][Full Text] [Related]
13. Facilitators and barriers to HIV pre-exposure prophylaxis (PrEP) uptake through a community-based intervention strategy among adolescent girls and young women in Seme Sub-County, Kisumu, Kenya.
Jackson-Gibson M; Ezema AU; Orero W; Were I; Ohiomoba RO; Mbullo PO; Hirschhorn LR
BMC Public Health; 2021 Jul; 21(1):1284. PubMed ID: 34210288
[TBL] [Abstract][Full Text] [Related]
14. Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study.
Haribhai S; Khadka N; Mvududu R; Mashele N; Bekker LG; Gorbach P; Coates TJ; Myer L; Joseph Davey DL
Int J STD AIDS; 2023 Jul; 34(8):548-556. PubMed ID: 36947792
[TBL] [Abstract][Full Text] [Related]
15. The Community PrEP Study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa-study protocol.
Medina-Marino A; Bezuidenhout D; Hosek S; Barnabas RV; Atujuna M; Bezuidenhout C; Ngwepe P; Peters RPH; Little F; Celum CL; Daniels J; Bekker LG
Trials; 2021 Jul; 22(1):489. PubMed ID: 34311754
[TBL] [Abstract][Full Text] [Related]
16. A qualitative analysis of the barriers and facilitators of HIV counselling and testing perceived by adolescents in South Africa.
Strauss M; Rhodes B; George G
BMC Health Serv Res; 2015 Jun; 15():250. PubMed ID: 26123133
[TBL] [Abstract][Full Text] [Related]
17. Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework.
Amico KR; Wallace M; Bekker LG; Roux S; Atujuna M; Sebastian E; Dye BJ; Elharrar V; Grant RM
AIDS Behav; 2017 May; 21(5):1361-1375. PubMed ID: 27317411
[TBL] [Abstract][Full Text] [Related]
18. Young Transgender Women's Attitudes Toward HIV Pre-exposure Prophylaxis.
Wood SM; Lee S; Barg FK; Castillo M; Dowshen N
J Adolesc Health; 2017 May; 60(5):549-555. PubMed ID: 28132744
[TBL] [Abstract][Full Text] [Related]
19. Gender norms, HIV risk, and attitudes towards pre-exposure prophylaxis and other HIV preventive interventions among South African adolescents.
Agaku I; Nkosi L; Gwar J; Tsafa T
Pan Afr Med J; 2022; 41():136. PubMed ID: 35519158
[TBL] [Abstract][Full Text] [Related]
20. Factors influencing adolescent girls and young women's uptake of community-based PrEP services following home-based HIV testing in Eastern Cape, South Africa: a qualitative study.
Mudzingwa EK; de Vos L; Atujuna M; Fynn L; Mugore M; Hosek S; Celum C; Bekker LG; Daniels J; Medina-Marino A
AIDS Behav; 2022 Nov; 26(11):3726-3739. PubMed ID: 35653046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
